Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Myopia

• A Study to Evaluate the Efficacy and Safety of Faricimab in Patients With Choroidal Neovascularization Secondary to Pathologic Myopia
• A Phase 3 Clinical Study of QLM3004 in Delaying Myopia in Children
• Effect of Atropine on Pupil Size and Quality of Vision
• the Efficacy of 0.01% Atropine for Near Work-induced Transient Myopia and Myopic Progression
• Delaying the Onset of Nearsightedness Until Treatment Study
• Effect of IOP Lowering on Progressive HM
• Myopia Control: a Comparison Study Between Atropine and MiSight
• Efficacy Comparison of 2 Low-dose Atropine Eye Drops in Vietnamese Children Myopia Management
• Efficacy of IVMED-85 on Pediatric Myopia
• Preservative-free Topical Anesthetics for Post-PRK Pain
• MAD Trial: Myopia Atropine Dose
• Efficacy and Safety of Low-concentration Atropine for Myopia Control in Chinese Children and Adolescents
• STudy of Atropine Therapeutic Effect on Myopic Progression
• Safety and Tolerability Evaluation of PRO-230 Ophthalmic Solution
• The Effects of Low-dose Atropine and Orthokeratology in Pediatric Myopia Control
• Phase I Clinical Trial to Evaluate the Safety and Tolerability of Ophtalmic Solution PRO-201
• Efficacy and Safety of 1% Atropine "5+3" Regimen in Children and Adolescents Controlling Myopia
• A-eyedrops on Ocular Alignment and Binocular Vision
• Myopia Intervention in Children and Adolescents and Establishment of a Precise Intervention Model
• Morphological Changes of Ciliary Body and Trabecular Meshwork
• Red Light Intervention on Myopic Progression
• The Response to Atropine Drops (RAD) Study
• Myopia Control in Children: Comparison of Defocus Incorporated Multiple Segments® Lenses Versus Atropine 0.05% Eyedrops
• Phase 1 Study of SHJ002 Sterile Ophthalmic Solution in Pediatric Subjects
• 601 Versus Ranibizumab in Patients With Pathological Myopic Choroidal Neovascularization (pmCNV)
• A Phase 1/2 Crossover Study to Assess EXP039 for Myopia or Hyperopia
• Study of OT-101 in Treating Myopia
• The Effect and Safety of Different Doses of Atropine on Myopic Progression of Highly Myopic Children: Multi-centered Randomized Clinical Trial
• Myopia Control With Novel Eye Drops
• Effect of Lowering IOP in Glaucoma Suspects With HM
• CM082 in Patients With Myopic Choroidal Neovascularization (CNV)
• Topical 0.01% Atropine for the Control of Fast Progressing Myopia
• Intravitreal Conbercept Injection in Patients With Myopic Choroidal Neovascularization
• Atropine for Children and Adolescent Myopia Progression Study
• Microdosed Atropine 0.1% and 0.01% Ophthalmic Solutions for Reduction of Pediatric Myopia Progression
• The Safety and Efficacy of SYD-101 in Children With Myopia
• Low-dose Atropine for the Prevention of Myopia Progression in Danish Children
• Low-dose AtropIne for Myopia Control in Children
• Short Term Refractive and Ocular Parameter Changes After Topical Atropine
• Evaluation of Short Term Use of Experimental Eye Drops BHVI2, 0.02% Atropine and BHVI2 Plus 0.02% Atropine Eye Drops
• Low-dose Atropine Eye Drops to Reduce Progression of Myopia in Children in the United Kingdom
• Side Effects of Atropine (SEA) Study
• Evaluation of Progression of Myopia in Children Treated With Vitamin B2 and Outdoor Sunlight Exposure
• The Effects of Low Dose Atropine on Choroidal Thickness
• Atropine 0.01% Eye Drops in Myopia Study
• Eye Drops Study for Myopia Control in Schoolchildren
• Topical Application of Low-concentration (0.01%) Atropine on the Human Eye With Fast and Slow Myopia Progression Rate
• CHAMP: Study of NVK-002 in Children With Myopia
• Low-Dose Atropine for Treatment of Myopia
• A Study Assessing the Efficacy and Safety of DE-127 Ophthalmic Solution in Subjects With Mild or Moderate Myopia (APPLE)
• The Influence of Atropine on Choroidal Thickness
• The Use of Atropine 0.01% in the Prevention and Control of Myopia (ATOM3)
• A Prospective Study to Evaluate the Raindrop Near Vision Inlay in Presbyopic Patients With Treatments to Optimize the Ocular Surface Before Implantation
• A Prospective Study To Evaluate The Raindrop Near Vision Inlay In Presybopic or Pseudophakic Patients Treated With Mitomycin C Following Femtosecond Flap Creation.
• Safety and Efficacy of Lotemax Versus FML in Subjects Undergoing PRK for the Correction of Mild to Moderate Myopia, 3- Month Follow-up Study
• Combined Atropine With Orthokeratology in Childhood Myopia Control (AOK) -A Randomized Controlled Trial
• The Effects of Low Concentration Atropine on Pupil Size and Accommodation
• Ocular Discomfort Assessment After Intravitreal Injections
• Echothiophate Iodide for the Prevention of Progression of Myopia
• VisuMax Femtosecond Laser Small Incision Lenticule Extraction for the Correction of High Myopia
• Corneal Epithelium Repair and Therapy Using Autologous Limbal Stem Cell Transplantation
• Low Concentration Atropine for Myopia Progression in School Children
• the Effect of Low-Concentration Atropine Combined With Auricular Acupoint Stimulation in Myopia Control
• A Study of the Criteria Establishing the Need for Re-treatment With Ranibizumab Upon Relapse in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia.
• Reduced-fluence Verteporfin Photodynamic Therapy Plus Ranibizumab for Choroidal Neovascularization in Pathologic Myopia
• Efficacy and Safety of Ranibizumab 0.5 vs Verteporfin PDT in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia
• A Randomized, Double-blind, Multicenter, Sham-controlled, Safety and Efficacy Study of Conbercept in Patients With mCNV
• Initial Treatment With Bevacizumab in Choroidal Neovascularization Associated to High Myopia
• Effect of Timolol on Refractive Outcomes in Eyes With Myopic Regression After LASIK: a Randomized Clinical Trial
• Mitomycin-c Application for PRK
• Bromday Versus Nevanac Eye Drops to Control Pain Following Photorefractive Keratectomy
• Safety and Efficacy Study of Combretastatin A4 Phosphate to Treat Patients With Choroidal Neovascularization Secondary to Pathologic Myopia
• Ranibizumab for Myopic Neovascularization
• Efficacy and Safety of Ranibizumab in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia
• Ranibizumab for the Treatment of Choroidal Neovascularisation (CNV) Secondary to Pathological Myopia (PM): an Individualized Regimen
• Study on the Effect of Mitomycin C 0.02% on the Corneal Endothelial After Photorefractive Keratectomy in Moderate Myopia
• Efficacy and Safety of Intravitreal Bevacizumab in the Treatment of Choroidal Neovascular Membranes Associated to High Myopia
• Intravitreal Bevacizumab and Low Fluence Photodynamic Therapy
• Bevacizumab Intravitreal for Myopic Choroidal Neovascularization
• Efficacy of PEG-400 and Systane Artificial Tears (Alcon) on Quality of Vision
• Evaluation of the Prophylactic Use of Mitomycin C 0.02% to Inhibit Haze Formation After Photorefractive Keratectomy for High Myopia: 15 x 30 Seconds
• Study of Myopia Prevention in Children With Low Concentration of Atropine
• Comparison of Lens Care Regimens With a Silicone Hydrogel Lens (Emerald)
• Myopia Control by Combining Auricular Acupoint and Atropine Eyedrops
• Bevicizumab (Avastin) Infusion for Choroidal Neovascularization (CNV) Not Associated With Age-Related Macular Degeneration (AMD)
• Safety and Efficacy Study of 0.5%, 0.1% & 0.01% Atropine Treatment to Both Eyes In Treatment of Myopia In Children
• Effects of Contact Lens Care Regimens on the Corneal Epithelium
• Investigation of Multi-Purpose Solution-Based Corneal Staining and Ocular Comfort
• Does Undercorrection of Myopia Retard Myopia Progression Among Kindergarten Children?
• Myopia Progression and the Effect of 7-Methylxanthine